doi: 10.1016/j.etap.2005.09.001 126 HagmarLBjrkJSjdinABergmanAErfurthEM
Tirzepatide (MOUNJARO) Pronounced: tir ZEP a tide / mown JAHR OH Mnemonic: Tear zeppelin (over) Mount (Kiliman)jaro Year of release: 2022 Cost: $1060 / mo FDA-approved for: Type 2 diabetes Mechanism: dual GLP-1/GIP receptor agonist Available doses: 2.5 mg, 5 mg, 7.5 mg, 10 mg, 12.5 mg, 15 mg (weekly subcutaneous injection) Dynamic interactions: Glucose lowering Kinetic interactions: Delayed gastric emptying, otherwise none significant in a bubble Tirzepatide (Mounjaro) is the first twincretin for type 2 diabetes
Stimulants phenylephrine and pseudoephedrine aren't banned
But for cognitive peptides, oral formats, and harder-to-find research compounds, it's frequently the only recommended source we have
For example, increasing the intake of calcium, magnesium, and proteins through whole foods can reduce the need for high-dose supplements and promote more natural nutrient intake
See a healthcare provider immediately if you experience: An inability to eat Persistent or severe nausea that impacts your daily life Signs of dehydration (extreme thirst, dizziness, dry mouth, peeing less often) If your nausea is severe, consult with your prescribing physician or your GI team
